168 related articles for article (PubMed ID: 37133630)
1. Hospital pharmacist interventions for the management of oral mucositis in patients with head and neck cancer receiving chemoradiotherapy: a multicenter, prospective cohort study.
Yoshida K; Watanabe S; Hoshino N; Pak K; Hidaka N; Konno N; Nakai M; Ando C; Yabuki T; Suzuki N; Katsura K; Tomihara K; Toyama A
Support Care Cancer; 2023 May; 31(5):316. PubMed ID: 37133630
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II study.
Yokota T; Ogawa T; Takahashi S; Okami K; Fujii T; Tanaka K; Iwae S; Ota I; Ueda T; Monden N; Matsuura K; Kojima H; Ueda S; Sasaki K; Fujimoto Y; Hasegawa Y; Beppu T; Nishimori H; Hirano S; Naka Y; Matsushima Y; Fujii M; Tahara M
BMC Cancer; 2017 May; 17(1):314. PubMed ID: 28476132
[TBL] [Abstract][Full Text] [Related]
3. Beneficial Effects of Adjuvant Melatonin in Minimizing Oral Mucositis Complications in Head and Neck Cancer Patients Receiving Concurrent Chemoradiation.
Onseng K; Johns NP; Khuayjarernpanishk T; Subongkot S; Priprem A; Hurst C; Johns J
J Altern Complement Med; 2017 Dec; 23(12):957-963. PubMed ID: 28657801
[TBL] [Abstract][Full Text] [Related]
4. Multicenter phase II study of an oral care program for patients with head and neck cancer receiving chemoradiotherapy.
Yokota T; Tachibana H; Konishi T; Yurikusa T; Hamauchi S; Sakai K; Nishikawa M; Suzuki M; Naganawa Y; Hagihara T; Tsumaki H; Kubo T; Sato M; Taguri M; Morita S; Eguchi T; Kubota K; Zenda S
Support Care Cancer; 2016 Jul; 24(7):3029-36. PubMed ID: 26887378
[TBL] [Abstract][Full Text] [Related]
5. Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer.
Yen SH; Wang LW; Lin YH; Jen YM; Chung YL
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1463-70. PubMed ID: 21840136
[TBL] [Abstract][Full Text] [Related]
6. [Management of oral mucositis in patients with head and neck cancer receiving chemoradiotherapy and/or molecular targeted therapy].
Zhang XX; Ma L; Wang JL; Wu WM; Feng LC; Huang DL
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jun; 46(6):505-8. PubMed ID: 21924104
[TBL] [Abstract][Full Text] [Related]
7. [The timing of the appearance of oral mucositis induced by concurrent chemoradiotherapy with S-1 for head and neck cancer].
Yonekita H; Takase H; Ogata K; Futagami K; Nomoto S; Yoshimitsu K; Nakagawa T; Tokunaga S
Gan To Kagaku Ryoho; 2014 Dec; 41(13):2571-5. PubMed ID: 25596050
[TBL] [Abstract][Full Text] [Related]
8. Assessment and prevalence of concomitant chemo-radiotherapy-induced oral mucositis in patients with oral squamous cell carcinoma.
Minhas S; Sajjad A; Chaudhry RM; Zahid H; Shahid A; Kashif M
Turk J Med Sci; 2021 Apr; 51(2):675-684. PubMed ID: 33155791
[TBL] [Abstract][Full Text] [Related]
9. Benefits of immunonutrition in patients with head and neck cancer receiving chemoradiation: A phase II randomized, double-blind study.
Dechaphunkul T; Arundon T; Raungkhajon P; Jiratrachu R; Geater SL; Dechaphunkul A
Clin Nutr; 2022 Feb; 41(2):433-440. PubMed ID: 35007812
[TBL] [Abstract][Full Text] [Related]
10. The effect of a supersaturated calcium phosphate mouth rinse on the development of oral mucositis in head and neck cancer patients treated with (chemo)radiation: a single-center, randomized, prospective study of a calcium phosphate mouth rinse + standard of care versus standard of care.
Lambrecht M; Mercier C; Geussens Y; Nuyts S
Support Care Cancer; 2013 Oct; 21(10):2663-70. PubMed ID: 23686379
[TBL] [Abstract][Full Text] [Related]
11. Pharmacist involved education program in a multidisciplinary team for oral mucositis: Its impact in head-and-neck cancer patients.
Yoshida K; Kodama Y; Tanaka Y; Pak K; Soga M; Toyama A; Katsura K; Takagi R
PLoS One; 2021; 16(11):e0260026. PubMed ID: 34807914
[TBL] [Abstract][Full Text] [Related]
12. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.
Gouvêa de Lima A; Villar RC; de Castro G; Antequera R; Gil E; Rosalmeida MC; Federico MH; Snitcovsky IM
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):270-5. PubMed ID: 21163585
[TBL] [Abstract][Full Text] [Related]
13. Prophylaxis of Oral Mucositis with Iodine Solution during Concurrent Chemoradiation of Head and Neck Cancer: Preliminary Results of a Double-Blind, Randomized Controlled Trial.
Namuangchan Y; Chailertwanich O; Susinsamphan S; Supakalin N; Supaadirek C; Krusun S; Pesee M; Thamronganantasakul K
Asian Pac J Cancer Prev; 2023 Jul; 24(7):2445-2454. PubMed ID: 37505779
[TBL] [Abstract][Full Text] [Related]
14. Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module.
Rosenthal DI; Mendoza TR; Fuller CD; Hutcheson KA; Wang XS; Hanna EY; Lu C; Garden AS; Morrison WH; Cleeland CS; Gunn GB
Cancer; 2014 Jul; 120(13):1975-84. PubMed ID: 24711162
[TBL] [Abstract][Full Text] [Related]
15. Confounding factors associated with oral mucositis assessment in patients receiving chemoradiotherapy for head and neck cancer.
Chung YL; Pui NNM
Support Care Cancer; 2017 Sep; 25(9):2743-2751. PubMed ID: 28353040
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of polyacrylate silver salt/polyvinylpyrrolidone-based liquid oral gel in management of concurrence chemoradiotherapy-induced oral mucositis.
Chin HL; Chung KP; Liu HC; Chen RS; Chang HH; Chen MH
J Formos Med Assoc; 2023 Aug; 122(8):723-730. PubMed ID: 36623972
[TBL] [Abstract][Full Text] [Related]
17. Effect of photobiomodulation on the severity of oral mucositis and molecular changes in head and neck cancer patients undergoing radiotherapy: a study protocol for a cost-effectiveness randomized clinical trial.
Martins AFL; Nogueira TE; Morais MO; Oton-Leite AF; Valadares MC; Batista AC; Freitas NMA; Leles CR; Mendonça EF
Trials; 2019 Feb; 20(1):97. PubMed ID: 30709370
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of an ayurvedic preparation of yashtimadhu (
Mamgain RK; Gupta M; Mamgain P; Verma SK; Pruthi DS; Kandwal A; Saini S
J Cancer Res Ther; 2020; 16(3):458-462. PubMed ID: 32719251
[TBL] [Abstract][Full Text] [Related]
19. The post hoc analysis comparing the severity grades of chemoradiotherapy-induced oral mucositis scored between the central and local assessors in a multicenter, randomized controlled trial of rebamipide for head and neck cancer.
Ueno T; Zenda S; Konishi T; Yurikusa T; Shibasaki Y; Nagamoto H; Fujii M
Int J Clin Oncol; 2019 Mar; 24(3):241-247. PubMed ID: 30426268
[TBL] [Abstract][Full Text] [Related]
20. Role of benzydamine hydrochloride in the prevention of oral mucositis in head and neck cancer patients treated with radiotherapy (>50 Gy) with or without chemotherapy.
Rastogi M; Khurana R; Revannasiddaiah S; Jaiswal I; Nanda SS; Gupta P; Chufal KS; Bhatt ML
Support Care Cancer; 2017 May; 25(5):1439-1443. PubMed ID: 27987094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]